Veristat
Partners & Customers
8Service Providers
1About Veristat
Veristat is a science-focused clinical research organization (CRO) supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies. Veristat offers comprehensive clinical development services, including biostatistics, statistical programming, medical writing, clinical monitoring, and data management for a single study or an entire clinical program, as well as preparation of integrated summary documents and submission-ready CDISC data for regulatory filings.
Want to inform investors similar to Veristat about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Veristat
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Veristat in 1 Expert Collection, including Telehealth.
Telehealth
2,856 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Latest Veristat News
May 23, 2023
SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation
Veristat Acquisitions
7 Acquisitions
Veristat acquired 7 companies. Their latest acquisition was Solutions for Life Sciences on March 07, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
3/7/2022 | Acquired | 3 | ||||
11/11/2021 | ||||||
2/25/2021 | ||||||
11/20/2020 | ||||||
1/6/2020 |
Date | 3/7/2022 | 11/11/2021 | 2/25/2021 | 11/20/2020 | 1/6/2020 |
|---|---|---|---|---|---|
Investment Stage | |||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acquired | ||||
Sources | 3 |
Veristat Partners & Customers
8 Partners and customers
Veristat has 8 strategic partners and customers. Veristat recently partnered with Origin BioSciences on March 3, 2021.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
3/8/2021 | Partner | United States | Veristat 's biostatisticians , programmers , and medical writers collaborated with Origin Biosciences to support the New Drug Application for Nulibry . | 4 | |
11/7/2018 | Client | ||||
11/5/2018 | Partner | ||||
6/19/2017 | Partner | ||||
1/12/2016 | Partner |
Date | 3/8/2021 | 11/7/2018 | 11/5/2018 | 6/19/2017 | 1/12/2016 |
|---|---|---|---|---|---|
Type | Partner | Client | Partner | Partner | Partner |
Business Partner | |||||
Country | United States | ||||
News Snippet | Veristat 's biostatisticians , programmers , and medical writers collaborated with Origin Biosciences to support the New Drug Application for Nulibry . | ||||
Sources | 4 |
Veristat Service Providers
1 Service Provider
Veristat has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Recap | Investment Bank | Financial Advisor |
Service Provider | |
|---|---|
Associated Rounds | Recap |
Provider Type | Investment Bank |
Service Type | Financial Advisor |
Partnership data by VentureSource
Veristat Team
9 Team Members
Veristat has 9 team members, including current Chief Executive Officer, Patrick Flanagan.
Name | Work History | Title | Status |
|---|---|---|---|
Patrick Flanagan | Certara, Sg2, Smith & Nephew, Intertrust, Kearney, and Baxter | Chief Executive Officer | Current |
Name | Patrick Flanagan | ||||
|---|---|---|---|---|---|
Work History | Certara, Sg2, Smith & Nephew, Intertrust, Kearney, and Baxter | ||||
Title | Chief Executive Officer | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.